Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №7 (2024) > Borderline ovarian tumors in women of childbearing age: diagnosis, treatment

Borderline ovarian tumors in women of childbearing age: diagnosis, treatment

Mekan R. Orazov , Marina V. Kiseleva , Vladlena M. Pernay

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Borderline ovarian tumors were first infected about 100 years ago. They are detected at an early stage and have a favorable outcome. But, as is known, relapse can begin within 20 years after therapy. Most often they occur in young women who are still interested in reproductive function, which influences the choice of further treatment tactics. Borderline ovarian tumors can indeed be challenging to diagnose based solely on clinical and ultrasound data. Accurate diagnosis often requires surgical intervention and histological examination of the tissue obtained. The review you mentioned likely covers various methods of diagnosis and treatment for borderline ovarian tumors, given the complexity of their diagnosis and management. Many discussions on this topic often address the challenges of accurate diagnosis and available treatment options. 
Keywords: borderline ovarian tumors, treatment, diagnosis, reproductive function.

About the Author

Mekan R. Orazov 1 , Marina V. Kiseleva 2 , Vladlena M. Pernay 1

1 Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russia

2 Tsyb Medical Radiological Research Centre – branch of the National Medical Research Center of Radiology, Obninsk, Russia

References

1. Bourdel N, Huchon C, Abdel Wahab C et al. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF). Eur J Obstet Gynecol Reprod Biol 2021;256:492-501.
2. Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch 2017;470(2):125-42.
3. Kipp B, Vidal A, Lenick D et al. Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland. J Ovarian Res 2023;16(1):20.
4. Du Bois A, Trillsch F, Mahner S et al. Management of borderline ovarian tumors. Ann Oncol 2016;27(Suppl 1):i20-i22. 
5. Taylor H. Malignant and semi-malignant tumors of the ovary. Surg Gynecol Obstet. 1929;48:204–230.
6. Serov SF, Scully RE, Solvin LH World Health Organization.  International Histologic Classification of Tumors. World Health Organization; Geneva: 1973. Hisological typing of ovarian tumors; pp. 37–41.
7. Meinhold-Heerlein I, Fotopoulou C, Harter P et al. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet 2016;293(4):695-700.
8. Plett H, Harter P, Ataseven B et al. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors. Gynecol Oncol 2020;157(2):411-7.
9. Bagade P, Edmondson R, Nayar A. Management of borderline ovarian tumours. Obstetric Gynaecol. 2012 Apr 1;14(2):115-20.
10. Güngördük K, Özdemir İA, Güngördük Ö et al. Effects of coffee consumption on gut recovery after surgery of gynecological cancer patients: a randomized controlled trial. Am J Obstet Gynecol 2017;216(2):145.e1-145.e7.
11. Sun H, Chen X, Zhu T et al. Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors. J Ovarian Res 2018;11(1):54.
12. Yilmaz E, Sahin N, Koleli I et al. Retrospective analysis of borderline ovarian tumors: outcomes at a single center. Acta Clin Croat 2019;58(1):29-36.
13. Chui MH, Kjaer SK, Frederiksen K et al. BRAFV600E – mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma. Oncotarget 2019;10(64):6870-78.
14. Malpica A, Wong KK. The molecular pathology of ovarian serous borderline tumors. Ann Oncol 2016;Suppl. 1(Suppl. 1):i16-i19.
15. Sun Y, Xu J, Jia X. The diagnosis, treatment, prognosis and molecular pathology of borderline ovarian tumors: Current Status and Perspectives. Cancer Manag Res 2020;12:3651-9.
16. Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Archiv 2017;470(2):125-42.
17. Tsang YT, Deavers MT, Sun CC et al KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. J Pathol 2013;231(4):449-56.
18. Wu H, Pangas SA, Eldin KW et al. Juvenile granulosa cell tumor of the ovary: a clinicopathologic study. J Pediatr Adolesc Gynecol 2017;30(1):138-43.
19. Солопова А.Г., Макацария А.Д., Солопова А.Е. и др. Склерокистозные яичники: современный взгляд на проблему. Акушерство, гинекология и репродукция. 2017;11(2):57-68. Solopova A.G., Makatsaria A.D., Solopova A.E. et al. Sclerocystic ovaries: a modern view of the problem. Obstetrics, gynecology and reproduction. 2017;11(2):57-68 (in Russian).
20. Crane EK. Thaker PH. Borderline tumors of the ovary. In: Textbook of Uncommon Cancer, 2017; 10.1002/9781119196235.ch40.
21. Niu L, Tian H, Xu Y et al. Recurrence characteristics and clinicopathological results of borderline ovarian tumors. BMC Womens Health 2021;21(1):134.
22. Maramai M, Barra F, Menada MV et al. Borderline ovarian tumours: management in the era of fertility-sparing surgery. Ecancermedicalscience 2020;(14):1031.
23. Давыдова И.Ю., Валиев Р.К., Карселадзе А.И. и др. Практические рекомендации по лечению пограничных опухолей яичников. Злокачественные опухоли. 2022;3S2-1. DOI: 10.18027/2224-5057-2020-10-3s2-12 Davydova I.Yu., Valiev R.K., Karseladze A.I. et al. Practical recommendations for the treatment of borderline ovarian tumors. Malignant tumors. 2022;3S2-1. DOI: 10.18027/2224-5057-2020-10-3s2-12 (in Russian).
24. Давыдова И.Ю., Кузнецов В.В., Карселадзе А.И., Мещерякова Л.А. Пограничные опухоли яичников. Акушерство и гинекология: новости, мнения, обучение. 2019;7(1):92-104. DOI: 10.24411/2303-9698-2019-11013 Davydova I.Yu., Kuznetsov V.V., Karseladze A.I., Meshcheryakova L.A. Borderline ovarian tumors. Obstetrics and gynecology: news, opinions, training. 2019;7(1):92-104. DOI: 10.24411/2303-9698-2019-11013 (in Russian).

For citation:Orazov M.R., Kiseleva M.V., Pernai V.M. Borderline ovarian tumors in women of childbearing age: diagnosis, treatment. Clinical analysis in general medicine. 2024; 5 (7): 83–90. (In Russ.). DOI: 10.47407/kr2024.5.7.00p424


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru